Detalhe da pesquisa
1.
A combination of cyclophosphamide and interleukin-2 allows CD4+ T cells converted to Tregs to control scurfy syndrome.
Blood
; 137(17): 2326-2336, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545713
2.
Rescuing the cytolytic function of APDS1 patient T cells via TALEN-mediated PIK3CD gene correction.
Mol Ther Methods Clin Dev
; 31: 101133, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38152700
3.
A DL-4- and TNFα-based culture system to generate high numbers of nonmodified or genetically modified immunotherapeutic human T-lymphoid progenitors.
Cell Mol Immunol
; 18(7): 1662-1676, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117371